Search Results 191-200 of 17413 for Mmol

1. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

   Fasting serum cholesterol ≤ 350 mg/dL (≤ 9.0 mmol/L); Triglycerides ≤ 1.5 x ULN (mg/dL or mmol/L); patients with triglyceride levels > 1.5 x ULN can be ...

2. Primary Hyperoxaluria Mutation Genotyping/Phenotyping - Mayo Clinic

   Patients with clinical suspicion of primary hyperoxaluria (elevated urine oxalate of greater than 0.8 mmol/1.73 m2/day (>70 mg/1.73 m2/day), history of ...

3. Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 - Mayo Clinic

   Cohort 4: ≥ 6 years to < 18 years (Note: the first participant in Cohort 4 must be ≥ 12 to < 18 years old). Mean of 2 valid 24-hour UOx ≥ 0.7 mmol/24 hours/ ...

4. Pyridorin in Diabetic Nephropathy - Clinical Trials

   ... mmol). Patients must have a SCr measurement <3.0 mg/dL (265 umol/L); Patients must have an eGFR of ≥20 mL/min/1.73m2, using the 4-variable Modification of ...

5. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 x upper limit of normal (ULN). Hepatic. Total bilirubin ≤1.5 x ULN; or; Direct bilirubin ...

6. EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) - Mayo Clinic

   Serum potassium > 5.5 mmol/L. Severe liver dysfunction (Childs-Pugh Class C). Acute coronary syndrome within 4 weeks as defined by electrocardiographic (ECG) ...

7. Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Mayo Clinic

   Synthetic liver dysfunction (albumin deficiency < 2.8 mmol/L) at screening; or 4. Diagnosis of liver fibrosis (Fibroscan > 7 kPa) confirmed by liver ...

8. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   Urine protein/creatinine ratio (UPCR) ≤ 1 mg/mg (≤ 113.2 mg/mmol). The subject is capable of understanding and complying with the protocol requirements ...

9. Losartan for Outpatients on COVID-19 - Clinical Trials

   Potassium > 5.0 mmol/L (must have been measured within 1 month) of enrollment. Concurrent treatment with aliskiren. Inability to obtain informed consent ...

10. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

    2h Post Glucose (PG) ≥ 200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test); or. Any (1) PDM present followed by an anti-diabetes medication ...